The NIH Common Fund Grant Opportunity Announcement2018-08-28T16:08:33-04:00
Funding Opportunities now available for the NIH Common Fund’s Acute to Chronic Pain Signatures program
The NIH Common Fund’s Acute to Chronic Pain Signatures program aims to understand the biological characteristics underlying the transition from acute to chronic pain and what makes some people susceptible and others resilient to the development of chronic pain. A2CPS is part of the NIH-wide HEAL (Helping to End Addiction Long-term) Initiative, an aggressive, trans-NIH effort to speed scientific solutions to stem the national opioid public health crisis. 
Summary:  The A2CPS program will collect data from: (1) patients with acute pain associated with a surgical procedure and (2) patients with acute pain from a musculoskeletal trauma such as a broken bone. Neuroimaging, high-throughput biomedical measurements, sensory testing, and psychosocial assessments collected periodically after the acute pain event will form a comprehensive data set to help predict which patients will develop long-lasting chronic pain. The goal of these studies is to identify individual patient features that together, will provide clinically meaningful, predictive “signatures” of transition or resilience to chronic pain.
The NIH is inviting applications for five funding opportunities: 
Applications are due October 24, 2018. An informational webinar will be held on September 6th, 2018 from 2-4 PM, EST. 
Join us via WebEx using this link:
Call-in toll number (US/Canada): 1-650-479-3208
Event number: 624 155 354
Event password: PainSig
For additional information about the A2CPS program, please visit and contact:
Linda L. Porter, Ph.D.  (RFA-RM-18-033RFA-RM-18-034RFA-RM-18-035)
National Institute on Neurological Disorders and Stroke (NINDS)
Telephone: 301-435-7572
John Satterlee, Ph.D.  (RFA-RM-18-031RFA-RM-18-032)
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1020
The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.  
The National Institutes of Health (NIH) –“The Nation’s Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about the NIH and its programs, visit the NIH website.
Go to Top